Alkermes Q1 2025 10-Q Filed
Ticker: ALKS · Form: 10-Q · Filed: May 1, 2025 · CIK: 1520262
| Field | Detail |
|---|---|
| Company | Alkermes PLC. (ALKS) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Alkermes Q1 2025 10-Q is in: Revenue from Vumerity & LYBALVI, assets & liabilities detailed.
AI Summary
Alkermes plc. filed a 10-Q for the period ending March 31, 2025. The filing details financial performance, including revenue from key products like Vumerity and LYBALVI. It also reports on assets such as buildings and certificates of deposit, and liabilities related to treasury stock.
Why It Matters
This filing provides investors with the latest financial snapshot of Alkermes plc., detailing revenue streams and asset/liability positions as of Q1 2025.
Risk Assessment
Risk Level: medium — The filing contains financial data that could indicate shifts in company performance, requiring careful analysis by investors.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial performance)
- 2025-03-31 — As of Date (End of the reporting period for financial statements)
Key Players & Entities
- Alkermes plc. (company) — Filer of the 10-Q
- Vumerity (product) — Product revenue
- LYBALVI (product) — Product revenue
- March 31, 2025 (date) — End of reporting period
- 20250331 (date) — Conformed period of report
FAQ
What were the key revenue drivers for Alkermes in Q1 2025?
The filing indicates revenue from products such as Vumerity and LYBALVI, as well as manufacturing revenue from other products and services.
What is the reporting period covered by this 10-Q filing?
The conformed period of report is March 31, 2025.
What types of assets are listed in the filing as of December 31, 2024?
The filing lists assets including buildings and improvements, and certificates of deposit.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the SEC file number for Alkermes plc.?
The SEC file number is 001-35299.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding Alkermes plc. (ALKS).